Victory Capital Management Inc Replimune Group, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$17.48 - $29.09 $2.01 Million - $3.34 Million	114,725 Added 19.9%	691,212 $12.2 Million
Q4 2022 Feb 09, 2023	BUY	$17.09 - $27.91 $9.85 Million - $16.1 Million	576,487 New	576,487 $15.7 Million
Q1 2022 May 04, 2022	SELL	$15.24 - $29.75 $13.8 Million - $26.9 Million	-904,573 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$25.43 - $34.25 $1.8 Million - $2.42 Million	70,729 Added 8.48%	904,573 $24.5 Million
Q3 2021 Nov 02, 2021	SELL	$28.98 - $39.54 $2.14 Million - $2.92 Million	-73,752 Reduced 8.13%	833,844 $24.7 Million
Q2 2021 Aug 03, 2021	SELL	$28.5 - $39.37 $4.5 Million - $6.21 Million	-157,826 Reduced 14.81%	907,596 $34.9 Million
Q1 2021 May 04, 2021	BUY	$30.22 - $45.57 $2.66 Million - $4.01 Million	88,029 Added 9.01%	1,065,422 $32.5 Million
Q4 2020 Feb 01, 2021	SELL	$23.5 - $52.65 $5.07 Million - $11.4 Million	-215,583 Reduced 18.07%	977,393 $37.3 Million
Q3 2020 Nov 09, 2020	BUY	$18.85 - $27.0 $1.36 Million - $1.94 Million	71,967 Added 6.42%	1,192,976 $27.5 Million
Q2 2020 Aug 07, 2020	BUY	$9.76 - $25.95 $6.56 Million - $17.5 Million	672,623 Added 150.01%	1,121,009 $27.9 Million
Q1 2020 May 04, 2020	BUY	$8.9 - $19.08 $1.05 Million - $2.25 Million	118,002 Added 35.72%	448,386 $4.47 Million
Q4 2019 Feb 06, 2020	SELL	$11.61 - $17.21 $7,755 - $11,496	-668 Reduced 0.2%	330,384 $4.74 Million
Q4 2019 Feb 04, 2020	BUY	$11.61 - $17.21 $362,139 - $536,814	31,192 Added 10.4%	331,052 $5.26 Million
Q3 2019 Nov 12, 2019	BUY	$10.01 - $16.87 $1.33 Million - $2.24 Million	132,680 Added 79.36%	299,860 $4.17 Million
Q2 2019 Aug 15, 2019	SELL	$12.51 - $17.28 $123,974 - $171,244	-9,910 Reduced 5.6%	167,180 $2.45 Million
Q1 2019 May 03, 2019	BUY	$10.26 - $16.24 $522,747 - $827,427	50,950 Added 40.39%	177,090 $2.7 Million
Q4 2018 Feb 05, 2019	SELL	$9.97 - $15.57 $21,535 - $33,631	-2,160 Reduced 1.68%	126,140 $1.26 Million
Q3 2018 Nov 01, 2018	BUY	$14.99 - $22.14 $1.92 Million - $2.84 Million	128,300 New	128,300 $2.07 Million

Others Institutions Holding REPL

# of Institutions

149

Shares Held

68M

Call Options Held

52.3K

Put Options Held

80.3K

Baker Bros. Advisors LP New York, NY

11M
Shares

$156 Million
1.3% of portfolio
Price T Rowe Associates Inc Baltimore, MD

9.88M
Shares

$139 Million
0.01% of portfolio
Fcpm Iii Services B.V. Naarden, P7

4.87M
Shares

$68.5 Million
9.16% of portfolio
Redmile Group, LLC San Francisco, CA

4.78M
Shares

$67.3 Million
3.43% of portfolio
Black Rock Inc. New York, NY

4.71M
Shares

$66.4 Million
0.0% of portfolio

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $694M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account